Literature DB >> 29979662

Merck vaccine heads Ebola countermeasures.

Cormac Sheridan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29979662     DOI： 10.1038/nbt0718-563a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.

Authors:  Davide Corti; John Misasi; Sabue Mulangu; Daphne A Stanley; Masaru Kanekiyo; Suzanne Wollen; Aurélie Ploquin; Nicole A Doria-Rose; Ryan P Staupe; Michael Bailey; Wei Shi; Misook Choe; Hadar Marcus; Emily A Thompson; Alberto Cagigi; Chiara Silacci; Blanca Fernandez-Rodriguez; Laurent Perez; Federica Sallusto; Fabrizia Vanzetta; Gloria Agatic; Elisabetta Cameroni; Neville Kisalu; Ingelise Gordon; Julie E Ledgerwood; John R Mascola; Barney S Graham; Jean-Jacques Muyembe-Tamfun; John C Trefry; Antonio Lanzavecchia; Nancy J Sullivan
Journal:  Science       Date:  2016-02-25       Impact factor: 47.728

2.  A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.

Authors:  Richard T Davey; Lori Dodd; Michael A Proschan; James Neaton; Jacquie Neuhaus Nordwall; Joseph S Koopmeiners; John Beigel; John Tierney; H Clifford Lane; Anthony S Fauci; Moses B F Massaquoi; Foday Sahr; Denis Malvy
Journal:  N Engl J Med       Date:  2016-10-13       Impact factor: 91.245

3.  Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Authors:  Ana Maria Henao-Restrepo; Anton Camacho; Ira M Longini; Conall H Watson; W John Edmunds; Matthias Egger; Miles W Carroll; Natalie E Dean; Ibrahima Diatta; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Pierre-Stéphane Gsell; Stefanie Hossmann; Sara Viksmoen Watle; Mandy Kader Kondé; Sakoba Kéïta; Souleymane Kone; Eewa Kuisma; Myron M Levine; Sema Mandal; Thomas Mauget; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; John-Arne Røttingen; Marie-Paule Kieny
Journal:  Lancet       Date:  2016-12-23       Impact factor: 79.321
  3 in total
  2 in total

1.  Phylodynamic Analysis of Ebola Virus Disease Transmission in Sierra Leone.

Authors:  Petrus Jansen van Vuren; Jason T Ladner; Antoinette A Grobbelaar; Michael R Wiley; Sean Lovett; Mushal Allam; Arshad Ismail; Chantel le Roux; Jacqueline Weyer; Naazneen Moolla; Nadia Storm; Joe Kgaladi; Mariano Sanchez-Lockhart; Ousman Conteh; Gustavo Palacios; Janusz T Paweska
Journal:  Viruses       Date:  2019-01-16       Impact factor: 5.048

2.  Ebola virus protein VP40 stimulates IL-12- and IL-18-dependent activation of human natural killer cells.

Authors:  Hung Le; Paul Spearman; Stephen N Waggoner; Karnail Singh
Journal:  JCI Insight       Date:  2022-08-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.